About
Saguaro Biosciences develops non-toxic fluorescent dyes for live-cell imaging (e.g., ChromaLIVE, NucleoLIVE, MortaLIVE) and sells these reagents to biotech and pharma customers. The company also offers drug-profiling services using high-content imaging and a reference dataset of 3,000+ annotated compounds.
Explore Saguaro Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.